AsOf

Regeneron Pharmaceuticals · CFOChristopher Fenimore

valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted

What the statuses mean

Valid from
2024-02-01
Valid until
still holds
Published
2026-04-24
Recorded by AsOf
2026-11-08
Checked
2026-11-09 · its source page states the value and the date
Confidence
0.95

Sources

“Effective February 2024, the board appointed Christopher Fenimore to succeed Robert E. Landry as the Company’s Chief Financial Officer upon Mr. Landry’s retirement.”— what the page says, read 2026-11-09

Cite this claim

Each form names the value, its as-of date (2024-02-01), the day you read it (2026-11-09), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text
AsOf. "Regeneron Pharmaceuticals cfo: Christopher Fenimore", as of 2024-02-01. Claim clm_0D057E1B2379, https://asof.is/claim/clm_0D057E1B2379, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm.
APA
AsOf. (2024). Regeneron Pharmaceuticals cfo: Christopher Fenimore (as of 2024-02-01) [Record clm_0D057E1B2379]. Retrieved November 9, 2026, from https://asof.is/claim/clm_0D057E1B2379 (source: https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm)
BibTeX
@misc{asof_clm_0D057E1B2379,
  author = {AsOf},
  title = {Regeneron Pharmaceuticals cfo: Christopher Fenimore},
  year = {2024},
  howpublished = {\url{https://asof.is/claim/clm_0D057E1B2379}},
  note = {Claim clm\_0D057E1B2379, as of 2024-02-01; source: https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm},
  urldate = {2026-11-09}
}

On the record

/claim/clm_0D057E1B2379.md/v1/claims/clm_0D057E1B2379submit a correction